期刊文献+

肿瘤相关物质检测在肿瘤早期诊断及疗效监测中的应用价值 被引量:5

Application value of Bo Xin tumor associated material in early diagnosis of tumor and monitoring of curative effect
下载PDF
导出
摘要 目的分析血清肿瘤相关物质(BXTM)在肿瘤早期诊断及疗效监测中的应用价值。方法收集中南大学湘雅医院2013年4月-2014年2月实验组800例癌症患者标本(肺癌、胃癌、食管癌、宫颈癌各200例)及对照组195例非癌症患者标本(102例健康体检及93例非癌疾患),采用BXTM试剂盒比较BXTM浓度在不同人群中的差异;同时收集各100例四种癌症患者标本,动态监测癌症患者治疗前后BXTM的浓度变化。结果血清BXTM浓度对恶性肿瘤的总体敏感性为75.38%,特异性为82.56%;实验组各肿瘤阳性率均〉70%,其中肺癌最高达78.0%,宫颈癌最低为73.0%,实验组各肿瘤阳性率明显高于对照组,差异具有统计学意义(P〈0.001);治疗后四种癌症患者BXTM浓度较治疗前平均下降10~15 U/ml,差异具有统计学意义(P〈0.001)。结论血清BXTM浓度检测可为肿瘤早期诊断提供有用的参考价值,具有较高的敏感性和特异性,同时可作为病情及疗效的动态监测指标。 【Objective】To analyze the application value of Bo Xin tumor associated material(BXTM) in the early diagnosis of tumor and monitoring of the curative effect.【Methods】Eight hundred specimens of the patients with cancer(200 cases of each of the lung cancer, gastric cancer, esophageal cancer and cervical cancer) in the experiment group and 195 specimens of the patients without cancer(102 cases of healthy check-up and 93 cases of noncancer diseases) in the control group were collected from April 2013 to February 2014 at Xiangya Hospital of Central South University. The difference of BXTM concentration in different groups was compared with the method of BXTM kit. Meanwhile 100 specimens were collected from each of four kinds of cancer patients, and the change of BXTM concentration before and after the treatment was dynamically monitored.【Results】The overall sensitivity of serum BXTM concentration in the malignant tumors was 75.38%, and the specificity was 82.56%. The positive rate of each tumor in the experimental group was higher than 70% with the highest positive rate of 78.0% in the lung cancer and the lowest positive rate of 73.0% in the cervical cancer, the positive rate of each tumor in the experimental group was significantly higher than that in the control group with a statistical difference(P〈0.001). The BXTM concentration of the four kinds of cancer after treatment decreased by an average of 10~15 U/ml than before treatment with a significant difference(P〈0.001).【Conclusions】The detection of BXTM concentration in serum can provide a useful reference value for the early diagnosis of tumors with high sensitivity and specificity. It can also be used as a dynamic monitoring index for patient's condition and curative effect.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第6期43-46,共4页 China Journal of Modern Medicine
关键词 肿瘤相关物质 肿瘤 诊断 动态监测 BXTM tumor diagnosis dynamic monitoring
  • 相关文献

参考文献11

  • 1KIMMAN M, NORMAN R,JAN S,et al. The burden of cancerin member countries of the Association of Southeast AsianNations (ASEAN) [J]. Asian Pac J Cancer Prev, 2012, 13 (2).
  • 2EKWUEME DU, GUY GP, LI C,et al. The health burden andeconomic costs of cutaneous melanoma mortality by race/ethnicity—United States, 2000 to 2006[J]. j Am Acad Dermatol, 2011, 65(5 Suppl 1): S133-143.
  • 3GRUSZEWSKA E,CHROSTEK L, CYLWIK B, et al. Serumsialic acid as a marker of pancreatic cancers[J]. Clin Lab, 2013,59(7-8): 781-788.
  • 4SAITO J, IMAMURA Y, ITOH J, et al. ELISA measurement forurinary 3—hydroxyproline—containing peptides and its preliminaryapplication to healthy persons and cancer patients [J]. AnticancerRes, 2010,30(3): 1007-1014.
  • 5ULLAH MF, AATIF M. The footprints of cancer development:Cancer biomarkers[J]. Cancer Treat Rev, 2009, 35(3): 193-200.
  • 6FERREIRA SA, VASCONCELOS JL,CAVALCANTI CL, et al.Sialic acid differential expression in non-melanoma skin cancerbiopsies[J]. Med Mol Morphol, 2013, 46(4): 198-202.
  • 7PRAKOBWONG S, CHAROENSUK L, HIRAKU Y, et al.Plasma hydroxyproline, MMP-7 and collagen I as novelpredictive risk markers of hepatobiliary disease—associatedcholangiocarcinoma[J]. Int J Cancer, 2012, 131(4): E416-424.
  • 8胜利,安利峰,史霖,王军阳,范桂香,袁育康.结肠癌患者外周血DcR3与CEA联合测定的临床价值[J].西安交通大学学报(医学版),2007,28(2):205-207. 被引量:7
  • 9吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 10HUMPHRIS JL, CHANG DK, JOHNS AL, et al. The prognosticand predictive value of serum CA19.9 in pancreatic cancer [J].Ann Oncol, 2012, 23(7): 1713-1722.

二级参考文献26

  • 1刘晓玲,汪涛,王雯,姜缨,郑伟.SCC-Ag、CEA在肺癌患者血清中的表达及临床意义[J].西安交通大学学报(医学版),2004,25(5):468-469. 被引量:7
  • 2罗素霞,马保根,陈小兵,肖毅军.LTA、CYFRA21-1、NSE和CEA联合检测对肺癌诊断及病理分型的价值[J].郑州大学学报(医学版),2005,40(6):1125-1127. 被引量:7
  • 3中华医学会检验医学分会肿瘤标志物专家委员会.肿瘤标志物检测临床应用的基本原则(讨论稿)[J].中华检验医学杂志,2004,:27-27.
  • 4王健 吉强 殷建华 等.AFP实验室检测40年[A]..肿瘤标志专题讨论会论文集[C].,2002.27-35.
  • 5Pritzker KH. Cancer biomarkers : easier said than done. Clin Chem, 2002,48: 1147- 1150.
  • 6Fleisher M, Dnistrian AM, Sturgeon CM, et al. Practice guidelines and recommendations for use tumor markers in the clinic. Washington DC: AACC Press,2002.20-25
  • 7Lichtenstein AV, Potapova GI. Genetic defects as tumor markers. Molecular Biol, 2003,37:159-169.
  • 8Lakhani SR, Ashworth A. Microarray and histo-pathological analysis of tumours:the future and the past? Nature Rev Cancer, 2001,1:151-157.
  • 9Yu H, Diamandis EP, Levesque M, et al. Prostate specific antigen in breast cancer benign breast disease and normal breast tissue. Breast Cancer Res Treat, 1996,40:171- 178.
  • 10Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003,3:267-275.

共引文献120

同被引文献69

  • 1杨传标,薛军,叶玉坤,徐克成.肺癌相关基因检测用于肺癌早期诊断研究进展[J].肿瘤学杂志,2004,10(5):360-362. 被引量:2
  • 2黄淑红,马晓丽,邱超,黄敬爱,孔维华,谢经武,张红卫.Cyclin B1、CDK1在肺癌中过表达及其意义[J].山东大学学报(理学版),2004,39(5):122-124. 被引量:4
  • 3杨艳,曹箭.肺癌早期诊断相关标记物的研究进展[J].诊断病理学杂志,2007,14(3):229-231. 被引量:3
  • 4叶晓丹,于红,肖湘生.肺癌早期诊断的研究进展[J].临床放射学杂志,2007,26(11):1155-1158. 被引量:5
  • 5Huang C,Zhao Q,Wu YM,et al.Study on relationship betweenmiR - 31 and eervicalcancer metastasis lymph [ J ].Modem obstetrics and Gynecology, 2013,2(4) : 253-258.
  • 6Dometshuber -Fleiss R, Hellos D, Mohr T, et al.The naturally born fusariotoxin Enniatin B and Sorafenib exert synergistic activity against cervical cancer in vitro and in vivo[J].Biochem Pharmacol, 2014,31 (12) : 295-308.
  • 7Cai L, Liu D, Lu S, et al.The relationship between geneexpression of Forkhead box C2 and tumor progression in cervical carcinoma [J].Eur J Gynaecol Oncol,2014,35 (6): 625-630.
  • 8Molli PR,Pradhan MB,Adwmi SH,et al.RhoA: a therapeutic target for chronic myeloid leukemia[J].Molecular eaneer,2012, 11 (16) : 1279-1287.
  • 9Kim JM,Kwon CH,Joh JW,te al.The effect of hepatocellular carcinoma bile duct tumor thrombi in liver transplantation [J]. Hepatogastrocnterology, 2014,61 ( 134 ) : 1673 - 1676.
  • 10Thie A, Fuhlendorf A, Spitzer K, et al.Transcranial Doppler evaluation of common and classic migraine.Part Ⅱ , Ultrasonic features during attacks [ J ].Headache, 1990,30 (4) : 209-215.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部